197 related articles for article (PubMed ID: 28641043)
1. Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.
Vargas HA; Huang EP; Lakhman Y; Ippolito JE; Bhosale P; Mellnick V; Shinagare AB; Anello M; Kirby J; Fevrier-Sullivan B; Freymann J; Jaffe CC; Sala E
Radiology; 2017 Nov; 285(2):482-492. PubMed ID: 28641043
[TBL] [Abstract][Full Text] [Related]
2. Association between morphologic CT imaging traits and prognostically relevant gene signatures in women with high-grade serous ovarian cancer: a hypothesis-generating study.
Vargas HA; Miccò M; Hong SI; Goldman DA; Dao F; Weigelt B; Soslow RA; Hricak H; Levine DA; Sala E
Radiology; 2015 Mar; 274(3):742-51. PubMed ID: 25383459
[TBL] [Abstract][Full Text] [Related]
3. High-Grade Serous Ovarian Cancer: Associations between BRCA Mutation Status, CT Imaging Phenotypes, and Clinical Outcomes.
Nougaret S; Lakhman Y; Gönen M; Goldman DA; Miccò M; D'Anastasi M; Johnson SA; Juluru K; Arnold AG; Sosa RE; Soslow RA; Vargas HA; Hricak H; Kauff ND; Sala E
Radiology; 2017 Nov; 285(2):472-481. PubMed ID: 28628421
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer.
McIntosh LJ; O'Neill AC; Bhanusupriya S; Matalon SA; Van den Abbeele AD; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2017 Oct; 42(10):2513-2520. PubMed ID: 28429056
[TBL] [Abstract][Full Text] [Related]
5. CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.
Nougaret S; Lakhman Y; Molinari N; Feier D; Scelzo C; Vargas HA; Sosa RE; Hricak H; Soslow RA; Grisham RN; Sala E
AJR Am J Roentgenol; 2018 Apr; 210(4):918-926. PubMed ID: 29489407
[TBL] [Abstract][Full Text] [Related]
6. Magnetic Resonance Imaging and Diffusion Weighted Imaging-Based Histogram in Predicting Mesenchymal Transition High-Grade Serous Ovarian Cancer.
Cai SQ; Song ZY; Wu MR; Lu JJ; Sun WW; Wei F; Li HM; Qiang JW; Li YA; Zhu J; Zhou JJ; Zeng MS
Acad Radiol; 2023 Jun; 30(6):1118-1128. PubMed ID: 35909051
[TBL] [Abstract][Full Text] [Related]
7. Integration of proteomics with CT-based qualitative and radiomic features in high-grade serous ovarian cancer patients: an exploratory analysis.
Beer L; Sahin H; Bateman NW; Blazic I; Vargas HA; Veeraraghavan H; Kirby J; Fevrier-Sullivan B; Freymann JB; Jaffe CC; Brenton J; Miccó M; Nougaret S; Darcy KM; Maxwell GL; Conrads TP; Huang E; Sala E
Eur Radiol; 2020 Aug; 30(8):4306-4316. PubMed ID: 32253542
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Cancer: Prevalence in Incidental Simple Adnexal Cysts Initially Identified in CT Examinations of the Abdomen and Pelvis.
Boos J; Brook OR; Fang J; Brook A; Levine D
Radiology; 2018 Jan; 286(1):196-204. PubMed ID: 28914598
[TBL] [Abstract][Full Text] [Related]
9. Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.
O'Neill AC; Somarouthu B; Tirumani SH; Braschi-Amirfarzan M; Van den Abbeele AD; Ramaiya NH; Shinagare AB
Radiology; 2017 Jan; 282(1):160-170. PubMed ID: 27479640
[TBL] [Abstract][Full Text] [Related]
10. Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
Lakhman Y; Akin O; Sohn MJ; Zheng J; Moskowitz CS; Iyer RB; Barakat RR; Sabbatini PJ; Chi DS; Hricak H
AJR Am J Roentgenol; 2012 Jun; 198(6):1453-9. PubMed ID: 22623562
[TBL] [Abstract][Full Text] [Related]
11. Differences in CT features of peritoneal carcinomatosis, sarcomatosis, and lymphomatosis: retrospective analysis of 122 cases at a tertiary cancer institution.
O'Neill AC; Shinagare AB; Rosenthal MH; Tirumani SH; Jagannathan JP; Ramaiya NH
Clin Radiol; 2014 Dec; 69(12):1219-27. PubMed ID: 25308238
[TBL] [Abstract][Full Text] [Related]
12. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion.
Akin O; Sala E; Moskowitz CS; Ishill N; Soslow RA; Chi DS; Hricak H
Radiology; 2008 Aug; 248(2):511-7. PubMed ID: 18519739
[TBL] [Abstract][Full Text] [Related]
13. Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.
Ohsuga T; Yamaguchi K; Kido A; Murakami R; Abiko K; Hamanishi J; Kondoh E; Baba T; Konishi I; Matsumura N
BMC Cancer; 2017 Aug; 17(1):580. PubMed ID: 28851311
[TBL] [Abstract][Full Text] [Related]
14. Characterizing morphologic subtypes of high-grade serous ovarian cancer by CT: a retrospective cohort study.
Foster KI; Handley KF; Glassman D; Sims TT; Javadi S; Palmquist SM; Saleh MM; Fellman BM; Fleming ND; Bhosale PR; Sood AK
Int J Gynecol Cancer; 2023 Jun; 33(6):937-943. PubMed ID: 36948527
[TBL] [Abstract][Full Text] [Related]
15. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A
Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976
[TBL] [Abstract][Full Text] [Related]
16. Advanced High-Grade Serous Ovarian Cancer: Frequency and Timing of Thoracic Metastases and the Implications for Chest Imaging Follow-up.
Shinagare AB; O'Neill AC; Cheng S; Somarouthu B; Tirumani SH; Nishino M; Van den Abbeele AD; Ramaiya NH
Radiology; 2015 Dec; 277(3):733-40. PubMed ID: 26053310
[TBL] [Abstract][Full Text] [Related]
17. Incidental adnexal masses detected at low-dose unenhanced CT in asymptomatic women age 50 and older: implications for clinical management and ovarian cancer screening.
Pickhardt PJ; Hanson ME
Radiology; 2010 Oct; 257(1):144-50. PubMed ID: 20663974
[TBL] [Abstract][Full Text] [Related]
18. HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Miller KR; Patel JN; Zhang Q; Norris EJ; Symanowski J; Michener C; Sehouli J; Braicu I; Destephanis DD; Sutker AP; Jones W; Livasy CA; Biscotti C; Ganapathi RN; Tait DL; Ganapathi MK
Gynecol Oncol; 2018 Apr; 149(1):155-162. PubMed ID: 29402501
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal implants from ovarian tumors: CT findings.
Buy JN; Moss AA; Ghossain MA; Sciot C; Malbec L; Vadrot D; Paniel BJ; Decroix Y
Radiology; 1988 Dec; 169(3):691-4. PubMed ID: 3186993
[TBL] [Abstract][Full Text] [Related]
20. Role of CT in the management of recurrent ovarian cancer.
Funt SA; Hricak H; Abu-Rustum N; Mazumdar M; Felderman H; Chi DS
AJR Am J Roentgenol; 2004 Feb; 182(2):393-8. PubMed ID: 14736669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
